October 14, 2026

Making Sense of MRD: One Tool for Monitoring Myeloma

When treatment for multiple myeloma is working well, it can eliminate most of the myeloma cells in your body. At that point, a very small number of cells may remain at levels that are too low for standard tests to pick up. That’s why your doctor may suggest testing for MRD, or minimal residual disease. […]

October 13, 2026

Highlights from IMS 2026 for Healthcare Providers – Advancing Myeloma Care: Better Management, Broader Access, Earlier Treatment

At this year’s International Myeloma Society (IMS) Annual Meeting, new data highlighted several areas of active research that can optimize treatment choice, delivery and tolerability in myeloma. Key themes for health care providers (HCPs) included: Preventing and managing treatment toxicity: Long-term cancer surveillance, infection prevention, immunoglobulin monitoring, ocular assessments and risk-adapted neurologic monitoring remain essential […]

October 12, 2026

New immunotherapy could offer hope for multiple myeloma patients – WVLT

October 12, 2026

New immunotherapy could offer hope for multiple myeloma patients – KPTV

October 12, 2026

New immunotherapy could offer hope for multiple myeloma patients – FOX 8 Live WVUE